ARMP - Armata Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARMP is currently covered by 1 analysts with an average price target of $6.86. This is a potential upside of $4.24 (161.83%) from yesterday's end of day stock price of $2.62.

Armata Pharmaceuticals's activity chart (see below) currently has 6 price targets and 7 ratings on display. The stock rating distribution of ARMP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 14.29% with an average time for these price targets to be met of 258 days.

Highest price target for ARMP is $7, Lowest price target is $7, average price target is $6.86.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 08-May-2024. First documented stock forecast 31-Oct-2019.

Best performing analysts who are covering ARMP - Armata Pharmaceuticals:

Joseph Pantginis

Currently out of the existing stock ratings of ARMP, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7

$4.38 (167.18%)

7

18 days ago

1/7 (14.29%)

$4.24 (153.62%)

258

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARMP (Armata Pharmaceuticals) average time for price targets to be met?

On average it took 258 days on average for the stock forecasts to be realized with a an average price target met ratio 14.29

Which analyst has the current highest performing score on ARMP (Armata Pharmaceuticals) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the most public recommendations on ARMP (Armata Pharmaceuticals)?

Joseph Pantginis has 16 price targets and 13 ratings on ARMP

Which analyst is the currently most bullish on ARMP (Armata Pharmaceuticals)?

Joseph Pantginis with highest potential upside - $4.38

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?